VNRX VolitionRx Limited

AMEX
$0.54

VolitionRx Limited (VNRX) is expected to report earnings on November 12, 2026, before the market open. The consensus earnings estimate is a loss of $0.69 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -13.3% since its last earnings release on August 13, 2026.

VolitionRx Limited Missed Consensus Estimates
Thursday, August 13, 2026 · 4:10 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 12
Thursday · Before Open
Earnings Whisper
-
vs ($0.69)
Rev est $770K
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $0.54

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About VolitionRx Limited

VolitionRX Ltd is a clinical-stage life sciences company. The Company is engaged in developing blood-based diagnostic tests for detecting and diagnosing cancer and other diseases.

Sector

Healthcare

Industry

Medical Labs & Research